Department of Surgery, Seoul National University College of Medicine, Seoul, South Korea.
Ann Surg. 2022 Jan 1;275(1):e206-e212. doi: 10.1097/SLA.0000000000003914.
The aim of the study was to present the safety and feasibility of pure laparoscopic donor right hepatectomy (PLDRH) in comparison with those of conventional donor right hepatectomy.
Although the use of PLDRH is gradually spreading worldwide, its outcomes, including the long-term outcomes in both donors and recipients, have not yet been evaluated in a large comparative study.
We retrospectively reviewed the medical records of 894 donors who underwent living donor liver transplantation between January 2010 and September 2018 at Seoul National University Hospital. We performed 1:1 propensity score matching between the PLDRH and conventional donor right hepatectomy groups. Subsequently, 198 donor-recipient pairs were included in each group.
The total operation time (P < 0.001), time to remove the liver (P < 0.001), and warm ischemic time (P < 0.001) were longer in the PLDRH group. None of the donors required intraoperative transfusion or experienced any irreversible disabilities or mortalities. The length of postoperative hospital stay was significantly shorter in the PLDRH group (P < 0.001). The rate of complications in donors was similar between the 2 groups. Although other complication rates in recipients were, however, similar, the rates of early (P = 0.019) and late (P < 0.001) biliary complications in recipients were higher in the PLDRH group. There was no significant difference in overall survival and graft survival between the 2 groups.
PLDRH is feasible when performed at an experienced living donor liver transplantation center. Further studies on long-term recipient outcomes including biliary complications are needed to confirm the safety.
本研究旨在介绍与传统右半肝切除术相比,纯腹腔镜供体右半肝切除术(PLDRH)的安全性和可行性。
虽然 PLDRH 的应用在全球范围内逐渐普及,但在一项大型对照研究中,尚未对其结果(包括供体和受者的长期结果)进行评估。
我们回顾性地分析了 2010 年 1 月至 2018 年 9 月期间在首尔国立大学医院接受活体肝移植的 894 名供者的病历。我们在 PLDRH 组和传统右半肝切除术组之间进行了 1:1 的倾向评分匹配。随后,每组纳入 198 对供者-受者。
PLDRH 组的总手术时间(P < 0.001)、切肝时间(P < 0.001)和热缺血时间(P < 0.001)均较长。没有供者需要术中输血,也没有发生任何不可逆转的残疾或死亡。PLDRH 组的术后住院时间明显缩短(P < 0.001)。两组供者的并发症发生率相似。虽然两组受者的其他并发症发生率相似,但 PLDRH 组受者的早期(P = 0.019)和晚期(P < 0.001)胆道并发症发生率较高。两组的总生存率和移植物生存率无显著差异。
在有经验的活体肝移植中心进行时,PLDRH 是可行的。需要进一步研究包括胆道并发症在内的受者长期结局,以确认其安全性。